Munich-based molecular diagnostics company GNA Biosolutions has completed US$13.5m Series C funding. New investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern joined the round as well as existing investors SHS…
Munich-based molecular diagnostics company GNA Biosolutions has completed US$13.5m Series C funding. New investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern joined the round as well as existing investors SHS…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference